PMID- 18708911 OWN - NLM STAT- MEDLINE DCOM- 20081209 LR - 20131121 IS - 1540-0514 (Electronic) IS - 1073-2322 (Linking) VI - 30 IP - 3 DP - 2008 Sep TI - Nitric oxide triggers delayed anesthetic preconditioning-induced cardiac protection via activation of nuclear factor-kappaB and upregulation of inducible nitric oxide synthase. PG - 241-9 LID - 10.1097/SHK.0b013e318162ad19 [doi] AB - Nitric oxide (NO) plays a pivotal role both in triggering and mediating delayed protection against myocardial I/R injury during anesthetic-induced preconditioning (APC). However, the signaling mechanisms that underlie this phenomenon remain unclear. Using isoflurane as a representative anesthetic, the present study tested the hypothesis that NO released after anesthetic-induced preconditioning initiates delayed cardioprotection via activation of nuclear transcription factor-kappaB (NF-kappaB), leading to myocardial adaptation by upregulation of iNOS and increase in production of NO. Sprague-Dawley rats that received open-chest surgery under pentobarbital anesthesia were subject to 30 min of left coronary artery occlusion, followed by 120 min of reperfusion. Exposure to 60 min of 2.1% isoflurane inhalation with oxygen 24 h before ischemia significantly reduced I/R-induced myocardial infarct size that was associated with overexpression of iNOS protein and increased NO content in the heart. These protective effects were abolished by pretreatment with a NOS inhibitor, N-nitro-L-arginine methyl ester, an NF-kappaB blocker, diethyldithiocarbamate, before isoflurane, or a selective iNOS inhibitor, S-methylisothiourea, before left coronary artery occlusion. Isoflurane exposure also evoked a robust increase in myocardial NO content, followed by nucleus-bound translocation of p65 or p50 subunit of NF-kappaB and increase in NF-kappaB DNA-binding activity in heart tissues. These molecular events after isoflurane exposure were blocked by pretreatment with N-nitro-L-arginine methyl ester. We conclude that NO generated immediately after isoflurane exposure triggers downstream activation of NF-kappaB, resulting in subsequent upregulation of iNOS expression and NO synthesis that mediate APC-induced delayed cardioprotection. FAU - Chen, Chen Hsiu AU - Chen CH AD - Department of Anesthesiology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, Republic of China. FAU - Chuang, Jiin Haur AU - Chuang JH FAU - Liu, Kang AU - Liu K FAU - Chan, Julie Y H AU - Chan JY LA - eng PT - Journal Article PL - United States TA - Shock JT - Shock (Augusta, Ga.) JID - 9421564 RN - 0 (Anesthetics, Inhalation) RN - 0 (NF-kappa B) RN - 0 (Protein C) RN - CYS9AKD70P (Isoflurane) RN - EC 1.14.13.39 (Nitric Oxide Synthase Type II) SB - IM MH - Anesthetics, Inhalation/pharmacology MH - Animals MH - Gene Expression Regulation, Enzymologic MH - Heart/*drug effects MH - Ischemic Preconditioning, Myocardial MH - Isoflurane/pharmacology MH - Male MH - Myocardium/*pathology MH - NF-kappa B/*metabolism MH - Nitric Oxide Synthase Type II/*biosynthesis MH - Protein C/metabolism MH - Rats MH - Rats, Sprague-Dawley MH - Reperfusion Injury MH - *Up-Regulation EDAT- 2008/08/19 09:00 MHDA- 2008/12/17 09:00 CRDT- 2008/08/19 09:00 PHST- 2008/08/19 09:00 [pubmed] PHST- 2008/12/17 09:00 [medline] PHST- 2008/08/19 09:00 [entrez] AID - 00024382-200809000-00003 [pii] AID - 10.1097/SHK.0b013e318162ad19 [doi] PST - ppublish SO - Shock. 2008 Sep;30(3):241-9. doi: 10.1097/SHK.0b013e318162ad19.